DNA Microarray Characterization of Pathogens Associated with Sexually Transmitted Diseases

Area of Science:

• Microbiology
• Molecular Diagnostics
• Public Health

Background:

• Sexually transmitted diseases (STDs) pose a significant global health challenge.
• Accurate and rapid detection of multiple STD pathogens is crucial for effective treatment and prevention.
• Current diagnostic methods can be time-consuming and may not cover a broad spectrum of pathogens simultaneously.

Purpose of the Study:

• To develop and validate a multiplex PCR-based microarray for the simultaneous detection of 17 common STD-associated pathogens.
• To establish a high-throughput, sensitive, and specific diagnostic tool for STDs.

Main Methods:

• Development of a multiplex PCR assay coupled with a microarray platform.
• Selection of specific target genes (16S rRNA, ompA, gB, L1) for each pathogen.
• Design and utilization of 34 probes, including specific, positive, negative, and positional control probes.
• Validation of specificity against commensal and pathogenic microbes.
• Assessment of sensitivity compared to standard multiplex PCR.

Main Results:

• The microarray successfully detected a diverse panel of 17 STD pathogens, including Neisseria gonorrhoeae, Chlamydia trachomatis, Mycoplasma genitalium, Mycoplasma hominis, Ureaplasma, HSV types 1 & 2, and multiple HPV types.
• The assay demonstrated high specificity, with no cross-reactivity observed.
• The microarray exhibited 10-fold higher sensitivity than conventional multiplex PCR.
• In a clinical sample analysis (158 suspected HPV specimens), the microarray identified various pathogens, including HPV (49 samples), Ureaplasma (21), M. hominis (15), C. trachomatis (4), and N. gonorrhoeae (1).

Conclusions:

• The developed multiplex PCR-based microarray is the first high-throughput system for identifying common STD pathogens from clinical samples.
• This technology represents a significant advancement towards a time-saving, accurate, and high-throughput diagnostic tool for STDs.
• The platform has the potential to improve STD diagnosis, management, and public health surveillance.